Summary: Psilocybin, the psychoactive compound found in many “magic mushrooms,” is well known for altering mood and perception in humans. Its effects on social behavior in animals are less understood. A recent study used the highly aggressive mangrove rivulus fish (Kryptolebias marmoratus) to test whether a low, acute dose of psilocybin alters social interactions and aggression.
Researchers found that a single low dose of psilocybin reduced high-energy attack behaviors while preserving basic social communication. The results suggest psilocybin selectively dampens escalation of conflict rather than broadly sedating social behavior.
Key facts
- Model organism: The mangrove rivulus is self-fertilizing and produces genetically identical offspring, allowing behavioral effects to be attributed to treatment rather than genetic variation.
- Selective de-escalation: Psilocybin decreased high-energy swimming bursts—aggressive maneuvers—while lower-energy social displays, such as head-on signaling, remained largely unaffected.
- Calming, not sedating: Although treated fish showed reduced overall movement, they continued to engage in social assessment. The drug appeared to reduce escalation rather than the motivation to interact.
- Vertebrate evidence: This study provides evidence in a vertebrate model that psilocybin can reduce escalated aggression without abolishing social communication.
- Serotonin pathways: Psilocybin acts on serotonin receptors. Because these systems are conserved across vertebrates, the findings offer insight into neural mechanisms that may be relevant to human social behavior and aggression.
Context
More than 200 species of mushrooms—many in the genus Psilocybe—contain psilocybin. In mammals, psilocybin binds to serotonin receptors and can influence mood, appetite, and aggressive behavior. Yet how this compound shapes social dynamics in other animals, especially vertebrates, remains underexplored. This study in Frontiers in Behavioral Neuroscience examined whether waterborne psilocybin influences social aggression and activity in the mangrove rivulus fish, an amphibious species known for high activity and frequent aggressive interactions.
Study design and methods
The research team used three genetically distinct laboratory lines of mangrove rivulus. One line provided focal fish exposed to psilocybin; a second line provided stimulus fish for social interaction tests; a third line was used to measure psilocybin absorption and whole-body concentrations. Using genetically identical lineages minimized confounding genetic differences and improved the study’s ability to detect drug effects.
For baseline measurements, a focal fish was placed into a tank containing a stimulus fish separated by a fiberglass mesh barrier covered with an opaque divider. This setup allowed visual and chemical cues but prevented physical contact. After a five-minute acclimation, the barrier was removed and interactions were recorded. Twenty-four hours later the same focal fish was exposed to a low concentration of psilocybin in water for 20 minutes, then reintroduced to the same stimulus fish and observed again after the divider was removed.
Main findings
Behavioral scoring focused on activity (time spent moving) and aggression (including swimming bursts). Fish treated with psilocybin showed a significant reduction in overall activity and a pronounced decrease in swimming bursts—rapid, high-energy maneuvers used to escalate aggression toward a conspecific. In contrast, lower-energy social displays such as head-on positioning and other assessment behaviors changed little.
The pattern of results indicates a selective dampening of energetically costly, escalated attacks, while leaving communication and social assessment intact. The research team interpreted this as evidence that psilocybin reduces the escalation of social conflict rather than causing a broad suppression of behavior or arousal.
Limitations and future directions
The authors caution that results from fish cannot be directly extrapolated to humans. This study assessed acute, single-dose exposure over a short timescale and did not examine repeated dosing, long-term consequences, or potential tolerance and adaptation. Substantial intraspecific variation in behavioral responses was also observed, suggesting individual differences that are not explained by genotype alone.
Future research should investigate the neural mechanisms behind these behavioral changes, identify which serotonin pathways mediate selective de-escalation, and test whether effects persist with repeated exposure or translate to other vertebrate models. Such work may help clarify which aspects of social behavior are most sensitive to psilocybin and inform potential therapeutic approaches for aggression-related conditions.
Questions answered
Q: If the fish move less, are they simply sedated?
A: The researchers report a selective effect. If the fish were broadly sedated, all social behaviors would decline. Instead, treated fish continued to communicate but engaged less in high-energy attacks, suggesting reduced escalation rather than general sedation.
Q: Does this study predict how psilocybin affects human aggression?
A: Direct extrapolation to humans is not possible, but conserved serotonin systems across vertebrates make these findings informative. The results hint that psilocybin may act on neural circuits that convert frustration into escalated aggression—an area of interest for therapeutic development.
Q: Why use a self-fertilizing fish that produces genetically identical offspring?
A: Using genetically identical individuals reduces variation from genetic differences, allowing clearer attribution of behavioral changes to the drug treatment itself.
Study abstract (summary)
Using isogenic lineages of the mangrove rivulus, the study found that waterborne psilocybin treatment significantly lowered activity levels and the frequency of aggressive swimming bursts toward a conspecific, with modest effects on other behaviors. These findings add to evidence that psilocybin can reduce escalated aggression in a vertebrate model and support further investigation into its mechanisms and therapeutic potential.
Source: Frontiers in Behavioral Neuroscience. Original research by Dayna Forsyth, Nicoletta Faraone, Simon G. Lamarre, and Suzanne Currie; study examined acute, low-dose psilocybin effects on social aggression in Kryptolebias marmoratus.